Swift Biosciences Enables COVID-19 Surveillance with NGS of Low Titer SARS-CoV-2 Specimens

Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift's assay enables research and surveillance activities by accommodating the low viral copy titers found in clinical specimens.